Server cans autism hope bumetanide after phase 3 fails

Servier and Neurochlore have been forced to admit defeat in their bid to bring the first drug to market for people with autism spectrum disorder (ASD), after a comprehensive fail for their

FDA grants swift approval to Cognoa's digital device for aut...

The FDA has approved a digital device developed by Cognoa that can be used to diagnose autism spectrum disorder (ASD), just a few weeks after it was filed for approval.

Cognoa files paediatric autism diagnosis device with FDA

Cognoa has filed for FDA approval of a digital device that could be used to diagnose autism, which the company argues could redefine care standards. 

Simple eye test could help screen kids for autism

Mobile app uses pictograms to help people with autism learn

A new mobile app aims to help people with autism spectrum disorders communicate better using a pictogram system, joining a crowded market for digital health tools helping people with the di

Roche’s autism drug granted FDA ‘breakthrough’ status

A drug which could become the first ever treatment for Autism Spectrum Disorder has been granted Breakthrough Therapy Designation by the FDA.